E

Evotec SE
D

EVO

1.51000
USD
-0.03
(-1.63%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
167
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
536,637,568
أصول ذات صلة

العنوان: Evotec SE

القطاع: الرعاية الصحية
الصناعة: Drug Manufacturers - Specialty & Generic
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.